Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Circulating Tumor Cells Revenue 1.4 Market Analysis by Type 1.4.1 Global Circulating Tumor Cells Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 CTC Enrichment 1.4.3 CTC Detection 1.4.4 CTC Analysis 1.5 Market by Application 1.5.1 Global Circulating Tumor Cells Market Share by Application: 2020 VS 2026 1.5.2 Breast Cancer 1.5.3 Prostate Cancer 1.5.4 Colorectal Cancer 1.5.5 Lung Cancer 1.5.6 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Circulating Tumor Cells Market Perspective (2015-2026) 2.2 Circulating Tumor Cells Growth Trends by Regions 2.2.1 Circulating Tumor Cells Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Circulating Tumor Cells Historic Market Share by Regions (2015-2020) 2.2.3 Circulating Tumor Cells Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Circulating Tumor Cells Market Growth Strategy 2.3.6 Primary Interviews with Key Circulating Tumor Cells Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Circulating Tumor Cells Players by Market Size 3.1.1 Global Top Circulating Tumor Cells Players by Revenue (2015-2020) 3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2015-2020) 3.1.3 Global Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Circulating Tumor Cells Market Concentration Ratio 3.2.1 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells Revenue in 2019 3.3 Circulating Tumor Cells Key Players Head office and Area Served 3.4 Key Players Circulating Tumor Cells Product Solution and Service 3.5 Date of Enter into Circulating Tumor Cells Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Circulating Tumor Cells Historic Market Size by Type (2015-2020) 4.2 Global Circulating Tumor Cells Forecasted Market Size by Type (2021-2026) 5 Circulating Tumor Cells Breakdown Data by Application (2015-2026) 5.1 Global Circulating Tumor Cells Market Size by Application (2015-2020) 5.2 Global Circulating Tumor Cells Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Circulating Tumor Cells Market Size (2015-2020) 6.2 Circulating Tumor Cells Key Players in North America (2019-2020) 6.3 North America Circulating Tumor Cells Market Size by Type (2015-2020) 6.4 North America Circulating Tumor Cells Market Size by Application (2015-2020) 7 Europe 7.1 Europe Circulating Tumor Cells Market Size (2015-2020) 7.2 Circulating Tumor Cells Key Players in Europe (2019-2020) 7.3 Europe Circulating Tumor Cells Market Size by Type (2015-2020) 7.4 Europe Circulating Tumor Cells Market Size by Application (2015-2020) 8 China 8.1 China Circulating Tumor Cells Market Size (2015-2020) 8.2 Circulating Tumor Cells Key Players in China (2019-2020) 8.3 China Circulating Tumor Cells Market Size by Type (2015-2020) 8.4 China Circulating Tumor Cells Market Size by Application (2015-2020) 9 Japan 9.1 Japan Circulating Tumor Cells Market Size (2015-2020) 9.2 Circulating Tumor Cells Key Players in Japan (2019-2020) 9.3 Japan Circulating Tumor Cells Market Size by Type (2015-2020) 9.4 Japan Circulating Tumor Cells Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Circulating Tumor Cells Market Size (2015-2020) 10.2 Circulating Tumor Cells Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Circulating Tumor Cells Market Size by Type (2015-2020) 10.4 Southeast Asia Circulating Tumor Cells Market Size by Application (2015-2020) 11 India 11.1 India Circulating Tumor Cells Market Size (2015-2020) 11.2 Circulating Tumor Cells Key Players in India (2019-2020) 11.3 India Circulating Tumor Cells Market Size by Type (2015-2020) 11.4 India Circulating Tumor Cells Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Circulating Tumor Cells Market Size (2015-2020) 12.2 Circulating Tumor Cells Key Players in Central & South America (2019-2020) 12.3 Central & South America Circulating Tumor Cells Market Size by Type (2015-2020) 12.4 Central & South America Circulating Tumor Cells Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Menarini-Silicon Biosystems 13.1.1 Menarini-Silicon Biosystems Company Details 13.1.2 Menarini-Silicon Biosystems Business Overview and Its Total Revenue 13.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Introduction 13.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2015-2020)) 13.1.5 Menarini-Silicon Biosystems Recent Development 13.2 Qiagen (Adnagen) 13.2.1 Qiagen (Adnagen) Company Details 13.2.2 Qiagen (Adnagen) Business Overview and Its Total Revenue 13.2.3 Qiagen (Adnagen) Circulating Tumor Cells Introduction 13.2.4 Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2015-2020) 13.2.5 Qiagen (Adnagen) Recent Development 13.3 Advanced Cell Diagnostics 13.3.1 Advanced Cell Diagnostics Company Details 13.3.2 Advanced Cell Diagnostics Business Overview and Its Total Revenue 13.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Introduction 13.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2015-2020) 13.3.5 Advanced Cell Diagnostics Recent Development 13.4 ApoCell 13.4.1 ApoCell Company Details 13.4.2 ApoCell Business Overview and Its Total Revenue 13.4.3 ApoCell Circulating Tumor Cells Introduction 13.4.4 ApoCell Revenue in Circulating Tumor Cells Business (2015-2020) 13.4.5 ApoCell Recent Development 13.5 Epic Sciences 13.5.1 Epic Sciences Company Details 13.5.2 Epic Sciences Business Overview and Its Total Revenue 13.5.3 Epic Sciences Circulating Tumor Cells Introduction 13.5.4 Epic Sciences Revenue in Circulating Tumor Cells Business (2015-2020) 13.5.5 Epic Sciences Recent Development 13.6 Greiner Bio-one GmbH 13.6.1 Greiner Bio-one GmbH Company Details 13.6.2 Greiner Bio-one GmbH Business Overview and Its Total Revenue 13.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Introduction 13.6.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2015-2020) 13.6.5 Greiner Bio-one GmbH Recent Development 13.7 Cynvenio 13.7.1 Cynvenio Company Details 13.7.2 Cynvenio Business Overview and Its Total Revenue 13.7.3 Cynvenio Circulating Tumor Cells Introduction 13.7.4 Cynvenio Revenue in Circulating Tumor Cells Business (2015-2020) 13.7.5 Cynvenio Recent Development 13.8 SurExamBio-Tech 13.8.1 SurExamBio-Tech Company Details 13.8.2 SurExamBio-Tech Business Overview and Its Total Revenue 13.8.3 SurExamBio-Tech Circulating Tumor Cells Introduction 13.8.4 SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2015-2020) 13.8.5 SurExamBio-Tech Recent Development 13.9 Fluxion Biosciences 13.9.1 Fluxion Biosciences Company Details 13.9.2 Fluxion Biosciences Business Overview and Its Total Revenue 13.9.3 Fluxion Biosciences Circulating Tumor Cells Introduction 13.9.4 Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2015-2020) 13.9.5 Fluxion Biosciences Recent Development 13.10 Ikonisys 13.10.1 Ikonisys Company Details 13.10.2 Ikonisys Business Overview and Its Total Revenue 13.10.3 Ikonisys Circulating Tumor Cells Introduction 13.10.4 Ikonisys Revenue in Circulating Tumor Cells Business (2015-2020) 13.10.5 Ikonisys Recent Development 13.11 Hangzhou Watson Biotech 10.11.1 Hangzhou Watson Biotech Company Details 10.11.2 Hangzhou Watson Biotech Business Overview and Its Total Revenue 10.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Introduction 10.11.4 Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2015-2020) 10.11.5 Hangzhou Watson Biotech Recent Development 13.12 Biocept 10.12.1 Biocept Company Details 10.12.2 Biocept Business Overview and Its Total Revenue 10.12.3 Biocept Circulating Tumor Cells Introduction 10.12.4 Biocept Revenue in Circulating Tumor Cells Business (2015-2020) 10.12.5 Biocept Recent Development 13.13 CytoTrack 10.13.1 CytoTrack Company Details 10.13.2 CytoTrack Business Overview and Its Total Revenue 10.13.3 CytoTrack Circulating Tumor Cells Introduction 10.13.4 CytoTrack Revenue in Circulating Tumor Cells Business (2015-2020) 10.13.5 CytoTrack Recent Development 13.14 Guangzhou Wondfo Biotech 10.14.1 Guangzhou Wondfo Biotech Company Details 10.14.2 Guangzhou Wondfo Biotech Business Overview and Its Total Revenue 10.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Introduction 10.14.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2015-2020) 10.14.5 Guangzhou Wondfo Biotech Recent Development 13.15 Celsee 10.15.1 Celsee Company Details 10.15.2 Celsee Business Overview and Its Total Revenue 10.15.3 Celsee Circulating Tumor Cells Introduction 10.15.4 Celsee Revenue in Circulating Tumor Cells Business (2015-2020) 10.15.5 Celsee Recent Development 13.16 Clearbridge Biomedics 10.16.1 Clearbridge Biomedics Company Details 10.16.2 Clearbridge Biomedics Business Overview and Its Total Revenue 10.16.3 Clearbridge Biomedics Circulating Tumor Cells Introduction 10.16.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2015-2020) 10.16.5 Clearbridge Biomedics Recent Development 13.17 ANGLE plc 10.17.1 ANGLE plc Company Details 10.17.2 ANGLE plc Business Overview and Its Total Revenue 10.17.3 ANGLE plc Circulating Tumor Cells Introduction 10.17.4 ANGLE plc Revenue in Circulating Tumor Cells Business (2015-2020) 10.17.5 ANGLE plc Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Circulating Tumor Cells Key Market Segments Table 2. Key Players Covered: Ranking by Circulating Tumor Cells Revenue Table 3. Ranking of Global Top Circulating Tumor Cells Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Circulating Tumor Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of CTC Enrichment Table 6. Key Players of CTC Detection Table 7. Key Players of CTC Analysis Table 8. Global Circulating Tumor Cells Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Circulating Tumor Cells Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Circulating Tumor Cells Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Circulating Tumor Cells Market Share by Regions (2015-2020) Table 12. Global Circulating Tumor Cells Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Circulating Tumor Cells Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Circulating Tumor Cells Market Growth Strategy Table 18. Main Points Interviewed from Key Circulating Tumor Cells Players Table 19. Global Circulating Tumor Cells Revenue by Players (2015-2020) (Million US$) Table 20. Global Circulating Tumor Cells Market Share by Players (2015-2020) Table 21. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells as of 2019) Table 22. Global Circulating Tumor Cells by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Circulating Tumor Cells Product Solution and Service Table 25. Date of Enter into Circulating Tumor Cells Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Circulating Tumor Cells Market Size by Type (2015-2020) (Million US$) Table 28. Global Circulating Tumor Cells Market Size Share by Type (2015-2020) Table 29. Global Circulating Tumor Cells Revenue Market Share by Type (2021-2026) Table 30. Global Circulating Tumor Cells Market Size Share by Application (2015-2020) Table 31. Global Circulating Tumor Cells Market Size by Application (2015-2020) (Million US$) Table 32. Global Circulating Tumor Cells Market Size Share by Application (2021-2026) Table 33. North America Key Players Circulating Tumor Cells Revenue (2019-2020) (Million US$) Table 34. North America Key Players Circulating Tumor Cells Market Share (2019-2020) Table 35. North America Circulating Tumor Cells Market Size by Type (2015-2020) (Million US$) Table 36. North America Circulating Tumor Cells Market Share by Type (2015-2020) Table 37. North America Circulating Tumor Cells Market Size by Application (2015-2020) (Million US$) Table 38. North America Circulating Tumor Cells Market Share by Application (2015-2020) Table 39. Europe Key Players Circulating Tumor Cells Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Circulating Tumor Cells Market Share (2019-2020) Table 41. Europe Circulating Tumor Cells Market Size by Type (2015-2020) (Million US$) Table 42. Europe Circulating Tumor Cells Market Share by Type (2015-2020) Table 43. Europe Circulating Tumor Cells Market Size by Application (2015-2020) (Million US$) Table 44. Europe Circulating Tumor Cells Market Share by Application (2015-2020) Table 45. China Key Players Circulating Tumor Cells Revenue (2019-2020) (Million US$) Table 46. China Key Players Circulating Tumor Cells Market Share (2019-2020) Table 47. China Circulating Tumor Cells Market Size by Type (2015-2020) (Million US$) Table 48. China Circulating Tumor Cells Market Share by Type (2015-2020) Table 49. China Circulating Tumor Cells Market Size by Application (2015-2020) (Million US$) Table 50. China Circulating Tumor Cells Market Share by Application (2015-2020) Table 51. Japan Key Players Circulating Tumor Cells Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Circulating Tumor Cells Market Share (2019-2020) Table 53. Japan Circulating Tumor Cells Market Size by Type (2015-2020) (Million US$) Table 54. Japan Circulating Tumor Cells Market Share by Type (2015-2020) Table 55. Japan Circulating Tumor Cells Market Size by Application (2015-2020) (Million US$) Table 56. Japan Circulating Tumor Cells Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Circulating Tumor Cells Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Circulating Tumor Cells Market Share (2019-2020) Table 59. Southeast Asia Circulating Tumor Cells Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Circulating Tumor Cells Market Share by Type (2015-2020) Table 61. Southeast Asia Circulating Tumor Cells Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Circulating Tumor Cells Market Share by Application (2015-2020) Table 63. India Key Players Circulating Tumor Cells Revenue (2019-2020) (Million US$) Table 64. India Key Players Circulating Tumor Cells Market Share (2019-2020) Table 65. India Circulating Tumor Cells Market Size by Type (2015-2020) (Million US$) Table 66. India Circulating Tumor Cells Market Share by Type (2015-2020) Table 67. India Circulating Tumor Cells Market Size by Application (2015-2020) (Million US$) Table 68. India Circulating Tumor Cells Market Share by Application (2015-2020) Table 69. Central & South America Key Players Circulating Tumor Cells Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Circulating Tumor Cells Market Share (2019-2020) Table 71. Central & South America Circulating Tumor Cells Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Circulating Tumor Cells Market Share by Type (2015-2020) Table 73. Central & South America Circulating Tumor Cells Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Circulating Tumor Cells Market Share by Application (2015-2020) Table 75. Menarini-Silicon Biosystems Company Details Table 76. Menarini-Silicon Biosystems Business Overview Table 77. Menarini-Silicon Biosystems Product Table 78. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 79. Menarini-Silicon Biosystems Recent Development Table 80. Qiagen (Adnagen) Company Details Table 81. Qiagen (Adnagen) Business Overview Table 82. Qiagen (Adnagen) Product Table 83. Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 84. Qiagen (Adnagen) Recent Development Table 85. Advanced Cell Diagnostics Company Details Table 86. Advanced Cell Diagnostics Business Overview Table 87. Advanced Cell Diagnostics Product Table 88. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 89. Advanced Cell Diagnostics Recent Development Table 90. ApoCell Company Details Table 91. ApoCell Business Overview Table 92. ApoCell Product Table 93. ApoCell Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 94. ApoCell Recent Development Table 95. Epic Sciences Company Details Table 96. Epic Sciences Business Overview Table 97. Epic Sciences Product Table 98. Epic Sciences Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 99. Epic Sciences Recent Development Table 100. Greiner Bio-one GmbH Company Details Table 101. Greiner Bio-one GmbH Business Overview Table 102. Greiner Bio-one GmbH Product Table 103. Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 104. Greiner Bio-one GmbH Recent Development Table 105. Cynvenio Company Details Table 106. Cynvenio Business Overview Table 107. Cynvenio Product Table 108. Cynvenio Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 109. Cynvenio Recent Development Table 110. SurExamBio-Tech Business Overview Table 111. SurExamBio-Tech Product Table 112. SurExamBio-Tech Company Details Table 113. SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 114. SurExamBio-Tech Recent Development Table 115. Fluxion Biosciences Company Details Table 116. Fluxion Biosciences Business Overview Table 117. Fluxion Biosciences Product Table 118. Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 119. Fluxion Biosciences Recent Development Table 120. Ikonisys Company Details Table 121. Ikonisys Business Overview Table 122. Ikonisys Product Table 123. Ikonisys Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 124. Ikonisys Recent Development Table 125. Hangzhou Watson Biotech Company Details Table 126. Hangzhou Watson Biotech Business Overview Table 127. Hangzhou Watson Biotech Product Table 128. Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 129. Hangzhou Watson Biotech Recent Development Table 130. Biocept Company Details Table 131. Biocept Business Overview Table 132. Biocept Product Table 133. Biocept Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 134. Biocept Recent Development Table 135. CytoTrack Company Details Table 136. CytoTrack Business Overview Table 137. CytoTrack Product Table 138. CytoTrack Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 139. CytoTrack Recent Development Table 140. Guangzhou Wondfo Biotech Company Details Table 141. Guangzhou Wondfo Biotech Business Overview Table 142. Guangzhou Wondfo Biotech Product Table 143. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 144. Guangzhou Wondfo Biotech Recent Development Table 145. Celsee Company Details Table 146. Celsee Business Overview Table 147. Celsee Product Table 148. Celsee Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 149. Celsee Recent Development Table 150. Clearbridge Biomedics Company Details Table 151. Clearbridge Biomedics Business Overview Table 152. Clearbridge Biomedics Product Table 153. Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 154. Clearbridge Biomedics Recent Development Table 155. ANGLE plc Company Details Table 156. ANGLE plc Business Overview Table 157. ANGLE plc Product Table 158. ANGLE plc Revenue in Circulating Tumor Cells Business (2015-2020) (Million US$) Table 159. ANGLE plc Recent Development Table 160. Research Programs/Design for This Report Table 161. Key Data Information from Secondary Sources Table 162. Key Data Information from Primary Sources List of Figures Figure 1. Global Circulating Tumor Cells Market Share by Type: 2020 VS 2026 Figure 2. CTC Enrichment Features Figure 3. CTC Detection Features Figure 4. CTC Analysis Features Figure 5. Global Circulating Tumor Cells Market Share by Application: 2020 VS 2026 Figure 6. Breast Cancer Case Studies Figure 7. Prostate Cancer Case Studies Figure 8. Colorectal Cancer Case Studies Figure 9. Lung Cancer Case Studies Figure 10. Other Case Studies Figure 11. Circulating Tumor Cells Report Years Considered Figure 12. Global Circulating Tumor Cells Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Circulating Tumor Cells Market Share by Regions: 2020 VS 2026 Figure 14. Global Circulating Tumor Cells Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Circulating Tumor Cells Market Share by Players in 2019 Figure 17. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Circulating Tumor Cells Revenue in 2019 Figure 19. North America Circulating Tumor Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Circulating Tumor Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Circulating Tumor Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Circulating Tumor Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Circulating Tumor Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Circulating Tumor Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Circulating Tumor Cells Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Menarini-Silicon Biosystems Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 28. Qiagen (Adnagen) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Qiagen (Adnagen) Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 30. Advanced Cell Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 32. ApoCell Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. ApoCell Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 34. Epic Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 36. Greiner Bio-one GmbH Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 38. Cynvenio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Cynvenio Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 40. SurExamBio-Tech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. SurExamBio-Tech Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 42. Fluxion Biosciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 44. Ikonisys Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Ikonisys Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 46. Hangzhou Watson Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Hangzhou Watson Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 48. Biocept Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Biocept Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 50. CytoTrack Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. CytoTrack Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 52. Guangzhou Wondfo Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 54. Celsee Total Revenue (US$ Million): 2019 Compared with 2018 Figure 55. Celsee Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 56. Clearbridge Biomedics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 57. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 58. ANGLE plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 59. ANGLE plc Revenue Growth Rate in Circulating Tumor Cells Business (2015-2020) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Menarini-Silicon Biosystems Qiagen (Adnagen) Advanced Cell Diagnostics ApoCell Epic Sciences Greiner Bio-one GmbH Cynvenio SurExamBio-Tech Fluxion Biosciences Ikonisys Hangzhou Watson Biotech Biocept CytoTrack Guangzhou Wondfo Biotech Celsee Clearbridge Biomedics ANGLE plc